| Bioactivity | PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin (IC50: 5.6 μM), thereby inhibiting the signaling of the Wnt/β-catenin pathway. PTK7/β-catenin-IN-2 targets cell growth dependent on the Wnt signaling pathway and has anticancer properties. PTK7/β-catenin-IN-2 also showed inhibitory potency against p53 and MDM2 binding with an IC50 of 157.1 μM[1]. |
| Target | IC50: 5.6 μM (Interaction between PTK7 and β-catenin); 157.1 μM (Interaction between p53 and MDM2) |
| CAS | 902434-29-1 |
| Formula | C30H34Cl2N6O |
| Molar Mass | 565.54 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Ganier L, et al. Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer[J]. ACS Chemical Biology, 2022, 17(5): 1061-1072. |
PTK7/β-catenin-IN-2
CAS: 902434-29-1 F: C30H34Cl2N6O W: 565.54
PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.